#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypereosinophilic syndrome Familial haemophagocytic lymphohistiocytosis Chronic myeloid leukaemia Human papilloma virus immunisation Extraskeletal ossification Myxoid liposarcoma Dermatitis Primitive neuroectodermal tumour Arteriosclerosis Peritoneal neoplasm Dent's disease Pyoderma gangrenosum Mycobacterium abscessus infection Bronchopulmonary dysplasia Myotonia More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma – Life with Disease Paroxysmal nocturnal haemoglobinuria – Life with Disease IgA nephropathy – Life with Disease Haemophilia A with anti factor VIII – Basic Information Medulloblastoma recurrent Langerhans cell sarcoma – Basic Information Rhabdomyosarcoma – Treatment Antithrombin III deficiency – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Treatment Angiosarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dazukibart 68Ga-Dpi-4452 ALLO-QUADCAR01-T Voclosporin Rct2100 Ly3537982 Odevixibat Aluminium Hydroxide Magnesium Chloride Perflubutane Sapropterin Dihydrochloride Pegipanermin Bisoprolol Cefepime Hydrochloride SEVUPARIN Dexibuprofen Istem-01 F1245/05 Tecaginlimab Menotrophin More therapies…

    Learn about Your Condition

    Dilated cardiomyopathy Coronary artery bypass Carcinoid tumour pulmonary Bronchostenosis Autoimmune uveitis Acute HIV infection BK virus infection Macular oedema Choreoathetosis Cold urticaria Brain neoplasm malignant Endometrial adenocarcinoma Cataract Laryngeal cancer stage III Retroperitoneal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hospital Universitario Mutua Terrassa

Hospital Universitario Mutua Terrassa

Plaza del Dr. Robert 5, Terrassa, 08221, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Temocillin and Meropenem for Patients with Infections Caused by Resistant Enterobacteriaceae

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial infection
    Investigated Drugs:
    • Ertapenem Sodium
    • Temocillin Sodium
    • Linezolid
    Spain

  • Study Comparing Linvoseltamab to Elotuzumab, Pomalidomide, and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    • Linvoseltamab
    • Elotuzumab
    Belgium France Germany Italy The Netherlands Poland +1

  • Study on Montelukast for Pain Relief in Patients with Erosive Hand Osteoarthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Montelukast
    Spain

  • Study of Immunotherapy Combinations Including Zimberelimab for Patients With Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Quemliclustat
    • Domvanalimab
    • Zimberelimab
    France Italy Poland Spain

  • Study on the Effectiveness and Safety of Imipenem, Cilastatin, and XNW4107 for Adults with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    Investigated Drugs:
    • (1R,4S)-4-(5-((S)-2-Iminioimidazolidin-4-Yl)-1,3,4- Oxadiazol-2-Yl)-6-Oxo-5,7- Diazaspiro[Bicyclo[3.2.1]Octane-2,1′-Cyclopropan]-7-Yl Sulfate
    • Imipenem
    • Relebactam
    France Spain

  • Study Comparing Lenalidomide, Bortezomib, Dexamethasone, Isatuximab, and Iberdomide for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Iberdomide
    • Bortezomib
    • Dexamethasone
    Spain
Previous Page
1 2 3

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!